[Seite 90↓]

Literaturverzeichnis

[1] Trey, C. und Davidson, C. S. (1970): The management of fulminant hepatic failure, Prog.Liver Dis. (Band 3:282-98), Seite 282-298.

[2] O'Grady, J. G. und Williams, R. (1986): Management of acute liver failure, Schweiz.Med.Wochenschr. (Band 116), Nr. 17, Seite 541-544.

[3] Bernal, W. und Wendon, J. (1999): Acute liver failure; clinical features and management, Eur.J.Gastroenterol.Hepatol. (Band 11), Nr. 9, Seite 977-984.

[4] Lee, W. M. (1993): Acute liver failure [published erratum appears in N Engl J Med 1994 Feb 24;330(8):584] [see comments], N.Engl.J.Med. (Band 329), Nr. 25, Seite 1862-1872.

[5] Lee, W. M. (1993): Acute liver failure [published erratum appears in N Engl J Med 1994 Feb 24;330(8):584] [see comments], N.Engl.J.Med. (Band 329), Nr. 25, Seite 1862-1872.

[6] O'Grady, J. G. und Williams, R. (1993): Classification of acute liver failure [letter], Lancet (Band 342), Nr. 8873, Seite 743.

[7] Horn, N.; Unger, J. und Rossaint, R. (1999): [Extracorporeal liver assist devices in acute liver failure], Anaesthesist. (Band 48), Nr. 6, Seite 387-394.

[8] McCashland, T. M.; Shaw, B. W. Jr und Tape, E. (1996): The American experience with transplantation for acute liver failure, Semin.Liver Dis. (Band 16), Nr. 4, Seite 427-433.

[9] Plevris, J. N.; Schina, M. und Hayes, P. C. (1998): Review article: the management of acute liver failure, Aliment.Pharmacol.Ther. (Band 12), Nr. 5, Seite 405-418.

[10] Gerok, W. (1985): [Metabolic principles in hepatic encephalopathy], Internist.(Berl.) (Band 26), Nr. 7, Seite 377-387.

[11] Gerok, W. und Haussinger, D. (1984): [Ammonium detoxication and pH regulation by the liver], Med.Welt. (Band 35), Nr. 1-2, Seite 28-34.

[12] Butterworth, R. F.; Giguere, J. F.; Michaud, J.; Lavoie, J. und Layrargues, G. P. (1987): Ammonia: key factor in the pathogenesis of hepatic encephalopathy, Neurochem.Pathol. (Band 6), Nr. 1-2, Seite 1-12.

[13] Arias, I. M.; Boyer, J. L.; Fausto, N.; Jakoby, W. B.; Schachter, D. A. und Shafritz, D. A. (1994): The liver: biology and pathobiology (Band 3rd edition), Raven Press, Ltd. New York.

[14] Gerok, W. and Haussinger, D.

[15] Gerok, W. (1985): [Metabolic principles in hepatic encephalopathy], Internist.(Berl.) (Band 26), Nr. 7, Seite 377-387.

[16] Gerok, W. und Haussinger, D. (1984): [Ammonium detoxication and pH regulation by the liver], Med.Welt. (Band 35), Nr. 1-2, Seite 28-34.

[17] Butterworth, R. F.; Giguere, J. F.; Michaud, J.; Lavoie, J. und Layrargues, G. P. (1987): Ammonia: key factor in the pathogenesis of hepatic encephalopathy, Neurochem.Pathol. (Band 6), Nr. 1-2, Seite 1-12.

[18] Hazell, A. S. und Butterworth, R. F. (1999): Hepatic encephalopathy: An update of pathophysiologic mechanisms, Proc.Soc.Exp.Biol.Med. (Band 222), Nr. 2, Seite 99-112.

[19] Butterworth, R. F. (1998): Effects of hyperammonaemia on brain function, J.Inherit.Metab.Dis. (Band 21 Suppl 1:6-20), Seite 6-20.


[Seite 91↓]

[20] Hawkins, R. A. und Jessy, J. (1991): Hyperammonaemia does not impair brain function in the absence of net glutamine synthesis, Biochem.J. (Band 277), Nr. Pt 3, Seite 697-703.

[21] Hazell, A. S. und Butterworth, R. F. (1999): Hepatic encephalopathy: An update of pathophysiologic mechanisms, Proc.Soc.Exp.Biol.Med. (Band 222), Nr. 2, Seite 99-112.

[22] Zieve, L. (1981): The mechanism of hepatic coma, Hepatology (Band 1), Nr. 4, Seite 360-365.

[23] Krebs, H. A.; Hems, R.; Lund, P.; Halliday, D. und Read, W. W. (1978): Sources of ammonia for mammalian urea synthesis, Biochem.J. (Band 176), Nr. 3, Seite 733-737.

[24] Haussinger, D. (1990): Nitrogen metabolism in liver: structural and functional organization and physiological relevance, Biochem.J. (Band 267), Nr. 2, Seite 281-290.

[25] Nissim, I.; Brosnan, M. E.; Yudkoff, M. und Brosnan, J. T. (1999): Studies of hepatic glutamine metabolism in the perfused rat liver with (15)N-labeled glutamine, J.Biol.Chem. (Band 274), Nr. 41, Seite 28958-28965.

[26] Haussinger, D. (1986): Regulation of hepatic ammonia metabolism: the intercellular glutamine cycle, Adv.Enzyme Regul. (Band 25:159-80), Seite 159-180.

[27] Lardner, A. L. und O'Donovan, D. J. (1998): Alterations in renal and hepatic nitrogen metabolism in rats during HCl ingestion, Metabolism (Band 47), Nr. 2, Seite 163-167.

[28] van den Berghe, G. (1991): The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism, J.Inherit.Metab.Dis. (Band 14), Nr. 4, Seite 407-420.

[29] DeFronzo, R. A. und Ferrannini, E. (1987): Regulation of hepatic glucose metabolism in humans, Diabetes Metab.Rev. (Band 3), Nr. 2, Seite 415-459.

[30] Thorens, B. (1992): Molecular and cellular physiology of GLUT-2, a high-Km facilitated diffusion glucose transporter, Int.Rev.Cytol. (Band 137:209-38), Seite 209-238.

[31] Cherrington, A. D.; Stevenson, R. W.; Steiner, K. E.; Davis, M. A.; Myers, S. R.; Adkins, B. A.; Abumrad, N. N. und Williams, P. E. (1987): Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo, Diabetes Metab.Rev. (Band 3), Nr. 1, Seite 307-332.

[32] Gardemann, A.; Puschel, G. P. und Jungermann, K. (1992): Nervous control of liver metabolism and hemodynamics, Eur.J.Biochem. (Band 207), Nr. 2, Seite 399-411.

[33] Ohno, K. und Maier, P. (1994): Cultured rat hepatocytes adapt their cellular glycolytic activity and adenylate energy status to tissue oxygen tension: influences of extracellular matrix components, insulin and glucagon, J.Cell Physiol. (Band 160), Nr. 2, Seite 358-366.

[34] Potin, M. und Perret, C. (1990): [Lactic acidosis and hyperlactatemia], Rev.Prat. (Band 40), Nr. 22, Seite 2042-2046.

[35] Zabrodski, R. M. und Schnurr, L. P. (1984): Anion gap acidosis with hypoglycemia in acetaminophen toxicity, Ann.Emerg.Med. (Band 13), Nr. 10, Seite 956-959.

[36] Silva, Y. J.; Parameswaran, P. G. und James, P. (1976): Exchange transfusion and major surgery in acute hepatic failure, Surgery (Band 80), Nr. 3, Seite 343-349.

[37] Horisawa, M. und Reynolds, T. B. (1976): Exchange transfusion in hepatorenal syndrome with liver disease, Arch.Intern.Med. (Band 136), Nr. 10, Seite 1135-1137.

[38] Kondrup, J.; Almdal, T.; Vilstrup, H. und Tygstrup, N. (1992): High volume plasma exchange in fulminant hepatic failure, Int.J.Artif.Organs (Band 15), Nr. 11, Seite 669-676.

[39] Matsubara, S. (1994): Combination of plasma exchange and continuous hemofiltration as temporary metabolic support for patients with acute liver failure, Artif.Organs (Band 18), Nr. 5, Seite 363-366.


[Seite 92↓]

[40] Freeman, J. G.; Matthewson, K. und Record, C. O. (1986): Plasmapheresis in acute liver failure, Int.J.Artif.Organs (Band 9), Nr. 6, Seite 433-438.

[41] Pott, G.; Krummenerl, T.; Lohmann, J. und Gerlach, U. (1983): [Diagnosis of acute liver failure], Dtsch.Med.Wochenschr. (Band 108), Nr. 35, Seite 1324-1327.

[42] McCauley, J.; Gaynord, M.; Hrinya, M. und Starzl, T. E. (1993): Dialysis in liver failure and liver transplantation, Transplant.Proc. (Band 25), Nr. 2, Seite 1740.

[43] Davenport, A. und Kirby, S. A. (1995): Intensive care management of patients with acute hepatic and renal failure, Contrib.Nephrol. (Band 116:22-7), Seite 22-27.

[44] Ash, S. R. (1994): Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites, Artif.Organs (Band 18), Nr. 5, Seite 355-362.

[45] O'Grady, J. G.; Gimson, A. E.; O'Brien, C. J.; Pucknell, A.; Hughes, R. D. und Williams, R. (1988): Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure, Gastroenterology (Band 94), Nr. 5 Pt 1, Seite 1186-1192.

[46] Tung, L. C.; Haring, R.; Waldschmidt, J. und Weber, D. (1980): [Experience in treating hepatic coma by extracorporal liver perfusion (author's transl)], Zentralbl.Chir. (Band 105), Nr. 18, Seite 1195-1205.

[47] Fox, I. J.; Langnas, A. N.; Fristoe, L. W.; Shaefer, M. S.; Vogel, J. E.; Antonson, D. L.; Donovan, J. P.; Heffron, T. G.; Markin, R. S. und Sorrell, M. F. (1993): Successful application of extracorporeal liver perfusion: a technology whose time has come, Am.J.Gastroenterol. (Band 88), Nr. 11, Seite 1876-1881.

[48] Waldschmidt, J.; Beck, G.; Botsch, H.; Dressler, S.; Hauck, W.; Haring, R.; Perez, R. de; Stallkamp, B. und Tung, L. C. (1971): [Clinical and experimental experiences with liver perfusion], Z.Exp.Chir. (Band 4), Nr. 4, Seite 209-215.

[49] Lie, T. S.; Dengler, H. J.; Gutgemann, A.; Rommelsheim, K.; Lelbach, W. K.; Holst, A.; Marsteller, H. J.; Ueda, T.; Muller, J.; Klehr, U.; von Bergmann, K.; Kutzner, M.; Speck, D. und Gundermann, K. J. (1977): [Extracorporeal perfusion with baboon liver in the treatment of hepatic coma (author's transl)], Dtsch.Med.Wochenschr. (Band 102), Nr. 42, Seite 1506-1511.

[50] Abouna, G. M. (1968): Experience with extracorporeal pig liver perfusion in the treatment of hepatic coma, Gut (Band 9), Nr. 6, Seite 730-731.

[51] Abouna, G. M.; Garry, R.; Hull, C.; Kirkley, J. und Walder, D. N. (1968): Pig-liver perfusion in hepatic coma, Lancet (Band 2), Nr. 7566, Seite 509-510.

[52] Chari, R. S.; Collins, B. H.; Magee, J. C.; DiMaio, J. M.; Kirk, A. D.; Harland, R. C.; McCann, R. L.; Platt, J. L. und Meyers, W. C. (1994): Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation [see comments], N.Engl.J.Med. (Band 331), Nr. 4, Seite 234-237.

[53] Satoh, S.; Terajima, H.; Yagi, T.; Kanazawa, A.; Shinohara, H.; Gomi, T.; Uesugi, T.; Yoneyama, T.; Ikai, I.; Takahashi, R.; Yamamoto, M. und Yamaoka, Y. (1997): Humoral injury in porcine livers perfused with human whole blood, Transplantation (Band 64), Nr. 8, Seite 1117-1123.

[54] Hammer, C. (1994): Fundamental problems of xenotransplantation, Pathol.Biol.(Paris.) (Band 42), Nr. 3, Seite 203-207.

[55] Abouna, G. M.; Cook, J. S.; Fisher, L. M.; Still, W. J.; Costa, G. und Hume, D. M. (1972): Treatment of acute hepatic coma by ex vivo baboon and human liver perfusions, Surgery (Band 71), Nr. 4, Seite 537-546.

[56] Terajima, H.; Shirakata, Y.; Yagi, T.; Mashima, S.; Shinohara, H.; Satoh, S.; Arima, Y.; Gomi, T.; Hirose, T.; Takahashi, R.; Ikai, I.; Morimoto, T.; Inamoto, T.; Yamamoto, M. und [Seite 93↓]Yamaoka, Y. (1997): Successful long-term xenoperfusion of the pig liver: continuous administration of prostaglandin E1 and insulin, Transplantation (Band 63), Nr. 4, Seite 507-512.

[57] Xu, Y.; Lorf, T.; Sablinski, T.; Gianello, P.; Bailin, M.; Monroy, R.; Kozlowski, T.; Awwad, M.; Cooper, D. K. und Sachs, D. H. (1998): Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column, Transplantation (Band 65), Nr. 2, Seite 172-179.

[58] Pascher, A.; Poehlein, C.; Stangl, M.; Hoebel, G.; Thiery, J.; Mueller-Derlich, J. und Hammer, C. (1997): Application of immunoapheresis for delaying hyperacute rejection during isolated xenogeneic pig liver perfusion, Transplantation (Band 63), Nr. 6, Seite 867-875.

[59] Fung, J.; Rao, A. und Starzl, T. (1997): Clinical trials and projected future of liver xenotransplantation, World J.Surg. (Band 21), Nr. 9, Seite 956-961.

[60] Starzl, T. E.; Fung, J.; Tzakis, A.; Todo, S.; Demetris, A. J.; Marino, I. R.; Doyle, H.; Zeevi, A.; Warty, V. und Michaels, M. (1993): Baboon-to-human liver transplantation [see comments], Lancet (Band 341), Nr. 8837, Seite 65-71.

[61] Starzl, T. E.; Tzakis, A.; Fung, J. J.; Todo, S.; Demetris, A. J.; Manez, R.; Marino, I. R.; Valdivia, L. und Murase, N. (1994): Prospects of clinical xenotransplantation, Transplant.Proc. (Band 26), Nr. 3, Seite 1082-1088.

[62] Hering, S.; Griffin, B. E. und Strauss, M. (1991): Immortalization of human fetal sinusoidal liver cells by polyoma virus large T antigen, Exp.Cell Res. (Band 195), Nr. 1, Seite 1-7.

[63] Sandig, V.; Hofmann, C.; Steinert, S.; Jennings, G.; Schlag, P. und Strauss, M. (1996): Gene transfer into hepatocytes and human liver tissue by baculovirus vectors, Hum.Gene Ther. (Band 7), Nr. 16, Seite 1937-1945.

[64] Alison, M. R.; Golding, M. H. und Sarraf, C. E. (1996): Pluripotential liver stem cells: facultative stem cells located in the biliary tree, Cell Prolif. (Band 29), Nr. 7, Seite 373-402.

[65] Brill, S.; Holst, P.; Sigal, S.; Zvibel, I.; Fiorino, A.; Ochs, A.; Somasundaran, U. und Reid, L. M. (1993): Hepatic progenitor populations in embryonic, neonatal, and adult liver, Proc.Soc.Exp.Biol.Med. (Band 204), Nr. 3, Seite 261-269.

[66] Sigal, S. H.; Brill, S.; Fiorino, A. S. und Reid, L. M. (1992): The liver as a stem cell and lineage system, Am.J.Physiol. (Band 263), Nr. 2 Pt 1, Seite G139-G148.

[67] Kim, B. H.; Sung, S. R.; Choi, E. H.; Kim, Y. I.; Kim, K. J.; Dong, S. H.; Kim, H. J.; Chang, Y. W.; Lee, J. I. und Chang, R.: Dedifferentiation of conditionally immortalized hepatocytes with long-term in vitro passage [In Process Citation], Exp.Mol.Med.2000.Mar.31.;32.(1.):29.-37. (Band 32), Nr. 1, Seite 29-37.

[68] Enosawa, S.; Suzuki, S.; Fujino, M.; Amemiya, H.; Omasa, T.; Urayama, S.; Tanimura, N. und Suga, K. (1997): An attempt to add biological functions by genetic engineering in order to produce high-performance bioreactor cells for hybrid artificial liver: transfection of glutamine synthetase into Chinese hamster ovary (CHO) cell, Cell Transplant. (Band 6), Nr. 5, Seite 537-540.

[69] Catapano, G.; Di Lorenzo, M. C.; Della, Volpe C.; De Bartolo, L. und Migliaresi, C. (1996): Polymeric membranes for hybrid liver support devices: the effect of membrane surface wettability on hepatocyte viability and functions, J.Biomater.Sci.Polym.Ed. (Band 7), Nr. 11, Seite 1017-1027.

[70] Gerlach, J. C.; Schnoy, N.; Encke, J.; Smith, M. D.; Muller, C. und Neuhaus, P. (1995): Improved hepatocyte in vitro maintenance in a culture model with woven multicompartment capillary systems: electron microscopy studies, Hepatology (Band 22), Nr. 2, Seite 546-552.

[71] Gerlach, J. C.; Schnoy, N.; Vienken, J.; Smith, M. und Neuhaus, P. (1996): Comparison of hollow fibre membranes for hepatocyte immobilisation in bioreactors, Int.J.Artif.Organs (Band [Seite 94↓]19), Nr. 10, Seite 610-616.

[72] Berry, M. N. und Friend, D. S. (1969): High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study, J.Cell Biol. (Band 43), Nr. 3, Seite 506-520.

[73] Seglen, P. O. (1972): Preparation of rat liver cells. I. Effect of Ca 2+ on enzymatic dispersion of isolated, perfused liver, Exp.Cell Res. (Band 74), Nr. 2, Seite 450-454.

[74] Seglen, P. O. (1973): Preparation of rat liver cells. II. Effects of ions and chelators on tissue dispersion, Exp.Cell Res. (Band 76), Nr. 1, Seite 25-30.

[75] Seglen, P. O. (1973): Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion, Exp.Cell Res. (Band 82), Nr. 2, Seite 391-398.

[76] Gerlach, J. C.; Brombacher, J.; Courtney, J. M. und Neuhaus, P. (1993): Nonenzymatic versus enzymatic hepatocyte isolation from pig livers for larger scale investigations of liver cell perfusion systems, Int.J.Artif.Organs (Band 16), Nr. 9, Seite 677-681.

[77] Gerlach, J. C.; Brombacher, J.; Kloppel, K.; Schnoy, N. und Neuhaus, P. (1994): Comparison of four methods for mass hepatocyte isolation from pig and human livers, Transplantation (Band 57), Nr. 9, Seite 1318-1322.

[78] Gerlach, J.; Brombacher, J.; Smith, M. und Neuhaus, P. (1996): High yield hepatocyte isolation from pig livers for investigation of hybrid liver support systems: influence of collagenase concentration and body weight, J.Surg.Res. (Band 62), Nr. 1, Seite 85-89.

[79] Bhatia, S. N.; Toner, M.; Tompkins, R. G. und Yarmush, M. L. (1994): Selective adhesion of hepatocytes on patterned surfaces, Ann.N.Y.Acad.Sci. (Band 745:187-209), Seite 187-209.

[80] Loreal, O.; Levavasseur, F.; Fromaget, C.; Gros, D.; Guillouzo, A. und Clement, B. (1993): Cooperation of Ito cells and hepatocytes in the deposition of an extracellular matrix in vitro, Am.J.Pathol. (Band 143), Nr. 2, Seite 538-544.

[81] Bader, A.; Knop, E.; Kern, A.; Boker, K.; Fruhauf, N.; Crome, O.; Esselmann, H.; Pape, C.; Kempka, G. und Sewing, K. F. (1996): 3-D coculture of hepatic sinusoidal cells with primary hepatocytes-design of an organotypical model, Exp.Cell Res. (Band 226), Nr. 1, Seite 223-233.

[82] Fujita, M.; Spray, D. C.; Choi, H.; Saez, J.; Jefferson, D. M.; Hertzberg, E.; Rosenberg, L. C. und Reid, L. M. (1986): Extracellular matrix regulation of cell-cell communication and tissue-specific gene expression in primary liver cultures, Prog.Clin.Biol.Res. (Band 226:333-60), Seite 333-360.

[83] te, Velde AA; Flendrig, L. M.; Ladiges, N. C. und Chamuleau, R. A. (1997): Immunological consequences of the use of xenogeneic hepatocytes in a bioartificial liver for acute liver failure, Int.J.Artif.Organs (Band 20), Nr. 4, Seite 229-233.

[84] Michalopoulos, G. K. (1995): HGF in liver regeneration and tumor promotion, Prog.Clin.Biol.Res. (Band 391:179-85), Seite 179-185.

[85] Stolz, D. B. und Michalopoulos, G. K. (1994): Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis, and signal transduction of primary rat hepatocytes, J.Cell Biochem. (Band 55), Nr. 4, Seite 445-464.

[86] Dich, J.; Vind, C. und Grunnet, N. (1988): Long-term culture of hepatocytes: effect of hormones on enzyme activities and metabolic capacity, Hepatology (Band 8), Nr. 1, Seite 39-45.

[87] Busse, B. und Gerlach, J. C. (1999): Bioreactors for hybrid liver support: historical aspects and novel designs, Ann.N.Y.Acad.Sci. (Band 875:326-39), Seite 326-339.

[88] Kay, M. A. und Fausto, N. (1997): Liver regeneration: prospects for therapy based on new technologies, Mol.Med.Today (Band 3), Nr. 3, Seite 108-115.

[89] Chen, S. C.; Hewitt, W. R.; Watanabe, F. D.; Eguchi, S.; Kahaku, E.; Middleton, Y.; Rozga, [Seite 95↓]J. und Demetriou, A. A. (1996): Clinical experience with a porcine hepatocyte-based liver support system, Int.J.Artif.Organs (Band 19), Nr. 11, Seite 664-669.

[90] Watanabe, F. D.; Mullon, C. J.; Hewitt, W. R.; Arkadopoulos, N.; Kahaku, E.; Eguchi, S.; Khalili, T.; Arnaout, W.; Shackleton, C. R.; Rozga, J.; Solomon, B. und Demetriou, A. A. (1997): Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial, Ann.Surg. (Band 225), Nr. 5, Seite 484-491.

[91] Rozga, J.; Holzman, M. D.; Ro, M. S.; Griffin, D. W.; Neuzil, D. F.; Giorgio, T.; Moscioni, A. D. und Demetriou, A. A. (1993): Development of a hybrid bioartificial liver, Ann.Surg. (Band 217), Nr. 5, Seite 502-509.

[92] Arkadopoulos, N.; Detry, O.; Rozga, J. und Demetriou, A. A. (1998): Liver assist systems: state of the art, Int.J.Artif.Organs (Band 21), Nr. 12, Seite 781-787.

[93] Rozga, J.; Podesta, L.; LePage, E.; Morsiani, E.; Moscioni, A. D.; Hoffman, A.; Sher, L.; Villamil, F.; Woolf, G. und McGrath, M. (1994): A bioartificial liver to treat severe acute liver failure, Ann.Surg. (Band 219), Nr. 5, Seite 538-544.

[94] Detry, O.; Arkadopoulos, N.; Ting, P.; Kahaku, E.; Watanabe, F. D.; Rozga, J. und Demetriou, A. A. (1999): Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure, Am.Surg. (Band 65), Nr. 10, Seite 934-938.

[95] Sussman, N. L. und Kelly, J. H. (1997): Extracorporeal liver support: cell-based therapy for the failing liver, Am.J.Kidney Dis. (Band 30), Nr. 5 Suppl 4, Seite S66-S71.

[96] Nyberg, S. L.; Remmel, R. P.; Mann, H. J.; Peshwa, M. V.; Hu, W. S. und Cerra, F. B. (1994): Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver, Ann.Surg. (Band 220), Nr. 1, Seite 59-67.

[97] Margulis, M. S.; Erukhimov, E. A.; Andreiman, L. A. und Viksna, L. M. (1989): Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency, Resuscitation. (Band 18), Nr. 1, Seite 85-94.

[98] Margulis, M. S.; Erukhimov, E. A.; Andreiman, L. A.; Kuznetsov, K. A.; Viksna, L. M.; Kuznetsov, A. I. und Deviatov, V. V. (1992): [The use of hemoperfusion through a suspension of cryopreserved hepatocytes in acute liver failure], Vestn.Khir.Im.I.I.Grek. (Band 148), Nr. 1, Seite 83-87.

[99] Thomas, L. (1988): Labor und Diagnose, Medizinische Verlagsgesellschaft mbH, Marburg.

[100] Haussinger, D. (1990): Nitrogen metabolism in liver: structural and functional organization and physiological relevance, Biochem.J. (Band 267), Nr. 2, Seite 281-290.

[101] Haussinger, D. (1990): Liver glutamine metabolism, JPEN.J.Parenter.Enteral.Nutr. (Band 14), Nr. 4 Suppl, Seite 56S-62S.

[102] Arkadopoulos, N.; Detry, O.; Rozga, J. und Demetriou, A. A. (1998): Liver assist systems: state of the art, Int.J.Artif.Organs (Band 21), Nr. 12, Seite 781-787.

[103] Margulis, M. S.; Erukhimov, E. A.; Andreiman, L. A. und Viksna, L. M. (1989): Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency, Resuscitation. (Band 18), Nr. 1, Seite 85-94.

[104] Margulis, M. S.; Erukhimov, E. A.; Andreiman, L. A.; Kuznetsov, K. A.; Viksna, L. M.; Kuznetsov, A. I. und Deviatov, V. V. (1992): [The use of hemoperfusion through a suspension of cryopreserved hepatocytes in acute liver failure], Vestn.Khir.Im.I.I.Grek. (Band 148), Nr. 1, Seite 83-87.

[105] Sussman, N. L. und Kelly, J. H. (1997): Extracorporeal liver support: cell-based therapy [Seite 96↓]for the failing liver, Am.J.Kidney Dis. (Band 30), Nr. 5 Suppl 4, Seite S66-S71.

[106] Watanabe, F. D.; Mullon, C. J.; Hewitt, W. R.; Arkadopoulos, N.; Kahaku, E.; Eguchi, S.; Khalili, T.; Arnaout, W.; Shackleton, C. R.; Rozga, J.; Solomon, B. und Demetriou, A. A. (1997): Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial, Ann.Surg. (Band 225), Nr. 5, Seite 484-491.

[107] Rozga, J.; Holzman, M. D.; Ro, M. S.; Griffin, D. W.; Neuzil, D. F.; Giorgio, T.; Moscioni, A. D. und Demetriou, A. A. (1993): Development of a hybrid bioartificial liver, Ann.Surg. (Band 217), Nr. 5, Seite 502-509.

[108] Greenway, C. V. und Stark, R. D. (1971): Hepatic vascular bed, Physiol.Rev. (Band 51), Nr. 1, Seite 23-65.

[109] Margulis, M. S.; Erukhimov, E. A.; Andreiman, L. A. und Viksna, L. M. (1989): Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency, Resuscitation. (Band 18), Nr. 1, Seite 85-94.

[110] Margulis, M. S.; Erukhimov, E. A.; Andreiman, L. A.; Kuznetsov, K. A.; Viksna, L. M.; Kuznetsov, A. I. und Deviatov, V. V. (1992): [The use of hemoperfusion through a suspension of cryopreserved hepatocytes in acute liver failure], Vestn.Khir.Im.I.I.Grek. (Band 148), Nr. 1, Seite 83-87.

[111] Sussman, N. L. und Kelly, J. H. (1997): Extracorporeal liver support: cell-based therapy for the failing liver, Am.J.Kidney Dis. (Band 30), Nr. 5 Suppl 4, Seite S66-S71.

[112] Rozga, J.; Holzman, M. D.; Ro, M. S.; Griffin, D. W.; Neuzil, D. F.; Giorgio, T.; Moscioni, A. D. und Demetriou, A. A. (1993): Development of a hybrid bioartificial liver, Ann.Surg. (Band 217), Nr. 5, Seite 502-509.

[113] Aldersley, M. A. und O'Grady, J. G. (1995): Hepatic disorders. Features and appropriate management, Drugs (Band 49), Nr. 1, Seite 83-102.

[114] Egbring, R. und Seitz, R. (1990): Improved prognosis of fulminant hepatic failure (FHF) after plasma derivative replacement therapy. Enhanced proteolysis of hemostatic proteins confirmed by proteinase-inhibitor complexes determination, Z.Gastroenterol. (Band 28), Nr. 2, Seite 104-109.

[115] Gerhardt, R. E.; Ntoso, K. A.; Koethe, J. D.; Lodge, S. und Wolf, C. J. (1992): Acute plasma separation with hemodialysis equipment, J.Am.Soc.Nephrol. (Band 2), Nr. 9, Seite 1455-1458.

[116] Wegmuller, E.; Montandon, A.; Nydegger, U. und Descoeudres, C. (1986): Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia, Int.J.Artif.Organs (Band 9), Nr. 2, Seite 85-92.

[117] LePage, E. B.; Lane, R.; McKay, D.; Rozga, J. und Demetriou, A. A. (1995): Plasma separation for artificial liver support, J.Clin.Apheresis. (Band 10), Nr. 2, Seite 70-75.

[118] Rehbinder, C.; Baneux, P.; Forbes, D.; van Herck, H.; Nicklas, W.; Rugaya, Z. und Winkler, G. (1998): FELASA recommendations for the health monitoring of breeding colonies and experimental units of cats, dogs and pigs. Report of the Federation of European Laboratory Animal Science Associations (FELASA) Working Group on Animal Health, Lab.Anim. (Band 32), Nr. 1, Seite 1-17.

[119] Shibata, R.; Miura, T.; Hayami, M.; Ogawa, K.; Sakai, H.; Kiyomasu, T.; Ishimoto, A. und Adachi, A. (1990): Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM), J.Virol. (Band 64), Nr. 2, Seite 742-747.

[120] Prusiner, S. B. (1994): Biology and genetics of prion diseases, Annu.Rev.Microbiol. (Band [Seite 97↓]48:655-86), Seite 655-686.

[121] Prusiner, S. B. (1997): Prion diseases and the BSE crisis, Science (Band 278), Nr. 5336, Seite 245-251.

[122] Bruce, M. E.; Will, R. G.; Ironside, J. W.; McConnell, I.; Drummond, D.; Suttie, A.; McCardle, L.; Chree, A.; Hope, J.; Birkett, C.; Cousens, S.; Fraser, H. und Bostock, C. J. (1997): Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent [see comments], Nature (Band 389), Nr. 6650, Seite 498-501.

[123] Tacke, S. J.; Kurth, R. und Denner, J.: Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation?, Virology 2000.Mar.1.;268.(1.):87.-93. (Band 268), Nr. 1, Seite 87-93.

[124] Pitkin, Z. und Mullon, C. (1999): Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system, Artif.Organs (Band 23), Nr. 9, Seite 829-833.

[125] Paradis, K.; Langford, G.; Long, Z.; Heneine, W.; Sandstrom, P.; Switzer, W. M.; Chapman, L. E.; Lockey, C.; Onions, D. und Otto, E. (1999): Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue [see comments], Science (Band 285), Nr. 5431, Seite 1236-1241.

[126] Cooke, S. P.; Hederer, R. A.; Pearson, J. D. und Savage, C. O. (1995): Characterization of human IgG-binding xenoantigens expressed by porcine aortic endothelial cells, Transplantation (Band 60), Nr. 11, Seite 1274-1284.

[127] Fujioka, H.; Cramer, D. V.; Yasunaga, C.; Tuso, P. J.; Wu, G. D.; Middleton, Y.; Moscioni, A. D.; Rozga, J.; Demetriou, A. A. und Makowka, L. (1995): Differential patterns of reaction of human natural antibodies to pig hepatocytes and vascular endothelium, Liver Transpl.Surg. (Band 1), Nr. 2, Seite 85-93.

[128] Baquerizo, A.; Mhoyan, A.; Kearns-Jonker, M.; Arnaout, W. S.; Shackleton, C.; Busuttil, R. W.; Demetriou, A. A. und Cramer, D. V. (1999): Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation, Transplantation (Band 67), Nr. 1, Seite 5-18.

[129] Bornemann, R.; Smith, M. D. und Gerlach, J. C. (1996): Consideration of potential immunological problems in the application of xenogenic hybrid liver support, Int.J.Artif.Organs (Band 19), Nr. 11, Seite 655-663.

[130] Hammer, C. und Molloy, B. (1993): Ethical aspects in xenotransplantation, Transplant.Proc. (Band 25), Nr. 4 Suppl 3, Seite 38-40.

[131] Daar, A. S. (1997): Ethics of xenotransplantation: animal issues, consent, and likely transformation of transplant ethics, World J.Surg. (Band 21), Nr. 9, Seite 975-982.

[132] Derenge, S. und Bartucci, M. R. (1999): Issues surrounding xenotransplantation, AORN.J. (Band 70), Nr. 3, Seite 428-432.

[133] Thomson, J. A. und Odorico, J. S.: Human embryonic stem cell and embryonic germ cell lines, Trends.Biotechnol.2000.Feb.;18.(2.):53.-7. (Band 18), Nr. 2, Seite 53-57.

[134] Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S. und Jones, J. M. (1998): Embryonic stem cell lines derived from human blastocysts [see comments] [published erratum appears in Science 1998 Dec 4;282(5395):1827], Science (Band 282), Nr. 5391, Seite 1145-1147.

[135] Gearhart, J. (1998): New potential for human embryonic stem cells [comment], Science (Band 282), Nr. 5391, Seite 1061-1062.


[Seite 98↓]

[136] Lenoir, N.: Europe confronts the embryonic stem cell research challenge, Science 2000.Feb.25.;287.(5457.):1425.-7. (Band 287), Nr. 5457, Seite 1425-1427.

[137] Branick, V. und Lysaught, M. T. (1999): Stem cell research: licit or complicit? Is a medical breakthrough based on embryonic and fetal tissue compatible with Catholic teaching?, Health Prog. (Band 80), Nr. 5, Seite 37-42.

[138] Young, F. E.: A time for restraint, Science 2000.Feb.25.;287.(5457.):1424. (Band 287), Nr. 5457, Seite 1424.

[139] Watanabe, F. D.; Mullon, C. J.; Hewitt, W. R.; Arkadopoulos, N.; Kahaku, E.; Eguchi, S.; Khalili, T.; Arnaout, W.; Shackleton, C. R.; Rozga, J.; Solomon, B. und Demetriou, A. A. (1997): Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial, Ann.Surg. (Band 225), Nr. 5, Seite 484-491.

[140] Liu, J.; Pan, J.; Naik, S.; Santangini, H.; Trenkler, D.; Thompson, N.; Rifai, A.; Chowdhury, J. R. und Jauregui, H. O. (1999): Characterization and evaluation of detoxification functions of a nontumorigenic immortalized porcine hepatocyte cell line (HepLiu), Cell Transplant. (Band 8), Nr. 3, Seite 219-232.

[141] Shi, Q.; Gaylor, J. D.; Cousins, R.; Plevris, J.; Hayes, P. C. und Grant, M. H. (1998): The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells, Artif.Organs (Band 22), Nr. 12, Seite 1023-1030.

[142] Thomson, J. A. und Odorico, J. S.: Human embryonic stem cell and embryonic germ cell lines, Trends.Biotechnol.2000.Feb.;18.(2.):53.-7. (Band 18), Nr. 2, Seite 53-57.

[143] Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S. und Jones, J. M. (1998): Embryonic stem cell lines derived from human blastocysts [see comments] [published erratum appears in Science 1998 Dec 4;282(5395):1827], Science (Band 282), Nr. 5391, Seite 1145-1147.

[144] Gearhart, J. (1998): New potential for human embryonic stem cells [comment], Science (Band 282), Nr. 5391, Seite 1061-1062.

[145] Kiassov, A. P.; Van Eyken, P.; van Pelt, J. F.; Depla, E.; Fevery, J.; Desmet, V. J. und Yap, S. H. (1995): Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study, Differentiation. (Band 59), Nr. 4, Seite 253-258.

[146] Fiorino, A. S.; Diehl, A. M.; Lin, H. Z.; Lemischka, I. R. und Reid, L. M. (1998): Maturation-dependent gene expression in a conditionally transformed liver progenitor cell line, In Vitro Cell Dev.Biol.Anim. (Band 34), Nr. 3, Seite 247-258.

[147] Brill, S.; Zvibel, I. und Reid, L. M. (1999): Expansion conditions for early hepatic progenitor cells from embryonal and neonatal rat livers, Dig.Dis.Sci. (Band 44), Nr. 2, Seite 364-371.

[148] Agelli, M.; Dello, Sbarba P.; Halay, E. D.; Faris, R. A.; Hixson, D. E. und Reid, L. M. (1997): Putative liver progenitor cells: conditions for long-term survival in culture, Histochem.J. (Band 29), Nr. 3, Seite 205-217.

[149] Petersen, B. E.; Bowen, W. C.; Patrene, K. D.; Mars, W. M.; Sullivan, A. K.; Murase, N.; Boggs, S. S.; Greenberger, J. S. und Goff, J. P. (1999): Bone marrow as a potential source of hepatic oval cells, Science (Band 284), Nr. 5417, Seite 1168-1170.

[150] Petersen, B. E.; Goff, J. P.; Greenberger, J. S. und Michalopoulos, G. K. (1998): Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat, Hepatology (Band 27), Nr. 2, Seite 433-445.

[151] Shiota, G.; Kunisada, T.; Oyama, K.; Udagawa, A.; Nomi, T.; Tanaka, K.; Tsutsumi, A.; Isono, M.; Nakamura, T.; Hamada, H.; Sakatani, T.; Sell, S.; Sato, K.; Ito, H. und Kawasaki, H.: [Seite 99↓]In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acetylaminofluorene/partial hepatectomy model in rats, FEBS Lett.2000.Mar.31.;470.(3.):325.-30. (Band 470), Nr. 3, Seite 325-330.

[152] Hewitt, W. R.; Corno, V.; Eguchi, S.; Kamlot, A.; Middleton, Y.; Beeker, T.; Demetriou, A. A. und Rozga, J. (1997): Isolation of human hepatocytes from livers rejected for whole organ transplantation, Transplant.Proc. (Band 29), Nr. 4, Seite 1945-1947.

[153] Kardassis, D.; Busse, B.; Besseling, A.; Kraemer, M.; Puhl, G.; Spatkowski, G.; Holland, G.; Schnoy, N.; Mueller, C.; Neuhaus, P. und Gerlach, J. (1999): Enzyme release in hybrid liver support systems: marker for quality prior to clinical application, Transplant.Proc. (Band 31), Nr. 1-2, Seite 668-669.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
21.01.2005